Challenges to Immunology Patents Lead Increase in Biotechnology Cases at the PTAB in 2017 -
Throughout the history of inter partes review (IPR) proceedings, petitions have been dominated by challenges to patents directed...more
New Testimonial Evidence with Preliminary Responses: Panacea or Placebo?
Just over three years ago, during a keynote speech at the AIPLA annual meeting, the Patent Trial and Appeal Board (PTAB) was criticized as a...more